| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610567A Enhanced systemic absorption of intradermally delivered substances |
| 04/27/2005 | CN1610557A 6-fluorobicyclo 3.1.0 hexane derivatives |
| 04/27/2005 | CN1610554A Chinese herbal medicine composition with treating heatstroke purpose and preparing method thereof |
| 04/27/2005 | CN1610551A Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610539A Pharmaceutical composition comprising a 5HT1 receptor agonist |
| 04/27/2005 | CN1609114A Notoginseng leaf total flavone and its prepn and application |
| 04/27/2005 | CN1609105A 1-methylolimidazole [1, 2-alpha] quinoxaline compound and its application |
| 04/27/2005 | CN1609086A MPTP affinity labels |
| 04/27/2005 | CN1608649A Chinese medicine health tonic for raising antisenility capacity and improving memory |
| 04/27/2005 | CN1608629A Compound panoxatriol saponin with physiological activity and its prepn and use |
| 04/27/2005 | CN1608628A Application of stevioside R1 and its derivative as medicine for preventing and treating neurodegeneration disease |
| 04/27/2005 | CN1608626A Fosphenytoin sodium powder for injection and its prepn |
| 04/27/2005 | CN1608623A Enteric coated donepezil hydrochloride tablet and its perpn process |
| 04/27/2005 | CN1608622A Solid dispersed Nimoldipine tablet and its prepn process |
| 04/27/2005 | CN1608556A Making process of insomnia treating pillow |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198936C Alzheimer's disease secretase |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198827C Selected derivatives of K-252a |
| 04/27/2005 | CN1198824C Polymorphs of N-methyl-N-(3-3-{2-thienylcarbonyl]-pyrazol -[1,5-alpha]-pyrimidin-7-yl}phenyl)a cetamide and compositions and methods related thereton |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198793C Ethers of methyl venlafaxine |
| 04/27/2005 | CN1198654C Pharmaceutical complex |
| 04/27/2005 | CN1198651C Composition comprising tramadol material and anticonvulsant drug |
| 04/27/2005 | CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 04/27/2005 | CN1198641C Antistress agents and functional foods |
| 04/27/2005 | CN1198636C Application of dandelion herb in preparing medicines |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198612C Use of imidazo [1, 2-a] pyridine -3 -acetamide derivs. for therapeutic treatment of neuropsychiatric syndromes associated with disfunction of neural circuits of basal ganglia |
| 04/27/2005 | CN1198610C Treatment of neurotic disorders |
| 04/27/2005 | CN1198608C Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides |
| 04/27/2005 | CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 04/27/2005 | CN1198598C Hydrophilic/lipophilic polymeric matrix dosage |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884910 Uses for amino acid anticonvulsants |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884888 Reacting mixture of N-(3-(3-(dimethylamino)-1-oxo-2-propenyl)phenyl)-N-ethylacetamide and 3-amino-4-cyanopyrazole in a liquid reaction medium; recovering |
| 04/26/2005 | US6884819 Administering to a Alzheimer's patient an effective amount of a (15R)-isocarbacycline compound to treat the disease |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884805 Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884596 A compound that is a Prolactin Releasing Peptide receptor (PrRP) agonist; determining the ability of the compound to promote wakefulness; providing a PrRP receptor antagonist and determining the ability of the compound to promote sleep |
| 04/26/2005 | US6884434 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2144728C Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035533A1 Modulators of serotonin receptors |
| 04/21/2005 | WO2005035532A1 Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors |
| 04/21/2005 | WO2005035531A1 POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION |
| 04/21/2005 | WO2005035526A1 Bicyclic compounds and their therapeutic use |
| 04/21/2005 | WO2005035523A1 Fused lactam compounds |
| 04/21/2005 | WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005035488A2 Thiophene-2-carboxamide derivatives and use thereof as cannabinoid cb-1 receptor antagonists |
| 04/21/2005 | WO2005034985A1 Agent for improving mental disorders |
| 04/21/2005 | WO2005034971A2 Antiviral agent |
| 04/21/2005 | WO2005034958A1 Triterpene compounds which are effective on improvement of brain function |
| 04/21/2005 | WO2005034932A2 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function |
| 04/21/2005 | WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists |
| 04/21/2005 | WO2005023741A3 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
| 04/21/2005 | WO2005004867A3 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |
| 04/21/2005 | WO2004110995A8 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 04/21/2005 | WO2004108119A3 Use of atp or derivatives in medicine |
| 04/21/2005 | WO2004106322A3 Polymorphs of aripiprazole |
| 04/21/2005 | WO2004094375A3 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
| 04/21/2005 | WO2004091593A3 Methods for the treatment of pain comprising opioid antagonists |
| 04/21/2005 | WO2004031174A8 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/21/2005 | WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 04/21/2005 | US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease |
| 04/21/2005 | US20050085860 Transdermal/transmucosal preparations for electroporation |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085553 Remedies for mild recognition deflict |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085533 Central nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/21/2005 | US20050085525 Method of treatment |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |